Análise secundária de um estudo randomizado | Duração da terapia antiplaquetária após intervenção coronariana percutânea complexa em pacientes sob alto risco de sangramento.

Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis – European Heart Journal

Comentários:

EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity – CardiovascularNews

One-Month DAPT Enough for Complex PCI if Bleeding Risk High – Medscape (necessário cadastro gratuito)

Comentário no Twitter

Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis https://t.co/0FX0Exj8sh @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/Ac8h0AkL42

— European Society of Cardiology Journals (@ESC_Journals) May 31, 2022